-
Most Recent
Search Results
240 results for CEL
Celsius Crypto Rocked by Lawsuit and Fund Mismanagement Allegations
The Celsius crypto is suffering hefty losses today as the company finds itself involved in a full-fledged lawsuit.
Hottest Services Stocks Now – FDO DG RBA ODP
Services stocks advanced broadly on Wall Street so far on Monday, with the sector seeing an overall increase of 0.2%.
Hottest Services Stocks Now – IRM MPEL MDCA CHU
Services stocks fell 0.5% on Wall Street on Thursday morning.
Can the Bulls Break S&P 1,200?
A breakout above this level will change the sentiment of the market.
The Top 5 Stocks Cathie Wood Bought and Sold This Week
Cathie Wood’s flagship ETF, the ARK Innovation ETF, hit a five-year and 52-week low this week, casting doubts on the investment manager.
8 Biotechnology Stocks to Sell Now
This week, the overall grades of eight biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
7 Top Global Dividend Stocks to Buy
Income investors willing to look beyond our borders can find generous yields with greater growth potential.
9 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of nine biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”)…
9 Biotechnology Stocks to Sell Now
The ratings of nine biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…
9 Biotechnology Stocks to Sell Now
The ratings of nine biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…
9 Biotechnology Stocks to Sell Now
The ratings of nine biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…
9 Biotechnology Stocks to Sell Now
The overall ratings of nine biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
Do Cryptos Really Need Regulation?
Regulation be the basis for cryptos moving even higher. And it’ll bring some clarity and certainty to these markets.
10 Biotechnology Stocks to Sell Now
This week, the overall grades of 10 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
10 Biotechnology Stocks to Sell Now
The overall ratings of 10 biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
10 Biotechnology Stocks to Sell Now
This week, the ratings of 10 biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
10 Biotechnology Stocks to Sell Now
This week, the ratings of 10 biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
10 Biotechnology Stocks to Sell Now
This week, the overall grades of 10 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…
10 Biotechnology Stocks to Sell Now
The overall ratings of 10 biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
10 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of 10 biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”)…
How Human Behavior Shapes Market Timing
If individual decisions surge and retreat at predictable moments, what happens when millions of people make those shifts at once?
10 Biotechnology Stocks to Sell Now
The overall ratings of 10 biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
10 Biotechnology Stocks to Sell Now
This week, the ratings of 10 biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
6 – 10 of 240 results
